Diethyl Hydrogen Phosphate

Diethyl Hydrogen Phosphate

SCHEMBL4951600

CCOP(=O)(O)OCC.CCn1ccnc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
FDPS P14324 4/20 0.47
GGPS1 O95749 3/20 0.45
LMNA P02545 2/20 0.45
BTN3A1 O00481 1/20 0.45
CA12 O43570 1/20 0.45
CA2 P00918 1/20 0.45
MMP2 P08253 1/20 0.45
MMP9 P14780 1/20 0.45
MMP8 P22894 1/20 0.45
MMP14 P50281 1/20 0.45
CA9 Q16790 1/20 0.45
CA14 Q9ULX7 1/20 0.45
ALDH1A1 P00352 2/20 0.41
KDM4E B2RXH2 2/20 0.39
TBXAS1 P24557 3/20 0.39
EGLN3 Q9H6Z9 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Diethyl Hydrogen Phosphate SCHEMBL4952771 0.87 FDPS (0.49) FDPSGGPS1LMNABTN3A1CA12
Phosphoric Acid SCHEMBL28686192 0.86 FDPS (0.56) FDPSGGPS1LMNABTN3A1CA12
Diethyl Hydrogen Phosphate SCHEMBL29204954 0.85 TBXAS1 (0.40) FDPSGGPS1LMNABTN3A1CA12
Diethyl Hydrogen Phosphate SCHEMBL4955346 0.84 TBXAS1 (0.57) FDPSLMNAKDM4ETBXAS1
Diethyl Hydrogen Phosphate SCHEMBL31154490 0.83 FDPS (0.42) FDPSGGPS1LMNABTN3A1CA12
Diethyl Hydrogen Phosphate SCHEMBL4951111 0.81 NFKB1 (0.52) FDPSGGPS1LMNABTN3A1CA12
SCHEMBL12350 0.78
SCHEMBL21332059 0.77 ALDH1A1 (0.53) ALDH1A1KDM4ETBXAS1EGLN3
Trimethyl Phosphate SCHEMBL28904473 0.77 FDPS (0.43) FDPSGGPS1LMNABTN3A1CA12
Diethyl Hydrogen Phosphate SCHEMBL28724449 0.77 FDPS (0.46) FDPSGGPS1LMNABTN3A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008022983-A2 CONDUCTIVE POLYMER GELS BASF SE (DE) 2008-02-28 WO claimed
EP-1663921-B1 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AG (DE) 2007-05-02 EP claimed
US-20070055084-A1 Method for producing haloalkanes from alcohols BASF AKTIENGESELLSCHAFT (DE) 2007-03-08 US claimed
WO-2008022983-A2 CONDUCTIVE POLYMER GELS BASF SE (DE) 2008-02-28 WO disclosed
EP-1663921-B1 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AG (DE) 2007-05-02 EP disclosed
US-20070055084-A1 Method for producing haloalkanes from alcohols BASF AKTIENGESELLSCHAFT (DE) 2007-03-08 US disclosed
EP-1663921-A2 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2006-06-07 EP disclosed
WO-2005026089-A2 METHOD FOR PRODUCING HALOALKANES FROM ALCOHOLS BASF AKTIENGESELLSCHAFT (DE) 2005-03-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070055084-A1 Method for producing haloalkanes from alcohols ADH1C, HDHD5, ADH5 FDPS 2441/4885GGPS1 1951/4885LMNA 1728/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.